For questions about financial assistance,
call 1-844-DUPIXENT, option 1 or
click to learn more
If your child is having trouble with food, it's time to learn how
DUPIXENT may be able to help.
DUPIXENT was studied in 61 patients ages 1 to 11 years old (≥33 lbs) with EoE in a two-part study.
*As measured by the Pediatric EoE Sign/Symptom Questionnaire-Caregiver
(PESQ-C).
The most common side effects
with EoE include:
View the possible side effects of DUPIXENT in patients with eosinophilic esophagitis.
DUPIXENT was also proven to reduce difficulty swallowing and reduce
inflammation in the esophagus in patients aged 12+ years.
Our goal is for you or your loved one to get the most out of your visit to the doctor. Fill out our personalized discussion guide to help yourself have a productive conversation during your next visit.
Use the Healthgrades™ tool to easily find nearby
specialists with experience in treating patients suffering
from eosinophilic esophagitis (EoE).
Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.
DUPIXENT is a biologic medicine given under the skin (subcutaneous injection). The
recommended dose for your child can depend on age and weight.
Sign up to get more information to help you and your child, including helpful tools and
resources, in your inbox with DUPIXENT MyWay® email updates.